State Key Laboratory of Medical Genomics at Ruijin Hospital, SJTU
医学基因组学国家重点实验室
China
1 December 2019 - 30 November 2020
Principal institution: Shanghai Institute of Hematology at Ruijin Hospital, SJTU
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for State Key Laboratory of Medical Genomics at Ruijin Hospital, SJTU published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 6 | 1.73 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 6 | 1.73 | |
Top articles by Altmetric score in current window
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
Proceedings of the National Academy of Sciences of the United States of America
2020-04-06
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
Cancer Cell
2020-03-16
PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS driven cancer cells
Journal of Biological Chemistry
2020-10-29
Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.
Proceedings of the National Academy of Sciences of the United States of America
2020-08-03
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
